HHS Releases Final Rule About 340B Ceiling Prices and Civil Monetary Penalties for Overcharging Covered Entities

On January 4, 2017, the Department of Health and Human Services (HHS) released the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties final rule. This rule implements a provision of the Affordable Care Act (ACA) that required HHS to publish the methods for calculating 340B ceiling prices and also imposes civil monetary […]